BR0015102A - Bactérias de ácido latico para o tratamento e/ou profilaxia de giardìase - Google Patents

Bactérias de ácido latico para o tratamento e/ou profilaxia de giardìase

Info

Publication number
BR0015102A
BR0015102A BR0015102-5A BR0015102A BR0015102A BR 0015102 A BR0015102 A BR 0015102A BR 0015102 A BR0015102 A BR 0015102A BR 0015102 A BR0015102 A BR 0015102A
Authority
BR
Brazil
Prior art keywords
prophylaxis
treatment
lactic acid
acid bacteria
giardiasis
Prior art date
Application number
BR0015102-5A
Other languages
English (en)
Other versions
BR0015102B1 (pt
Inventor
Eduardo Schiffrin
Pablo Perez
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of BR0015102A publication Critical patent/BR0015102A/pt
Publication of BR0015102B1 publication Critical patent/BR0015102B1/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1234—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt characterised by using a Lactobacillus sp. other than Lactobacillus Bulgaricus, including Bificlobacterium sp.
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/12—Fermented milk preparations; Treatment using microorganisms or enzymes
    • A23C9/123—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt
    • A23C9/1236—Fermented milk preparations; Treatment using microorganisms or enzymes using only microorganisms of the genus lactobacteriaceae; Yoghurt using Leuconostoc, Pediococcus or Streptococcus sp. other than Streptococcus Thermophilus; Artificial sour buttermilk in general
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Dairy Products (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

"BACTéRIAS DE áCIDO LáTICO PARA O TRATAMENTO E/OU PROFILAXIA DE GIARDìASE". A presente invenção refere-se ao uso de um sobrenadante de bactérias de ácido lático ou,de Bifidobactérias capazes de prevenirem colonização de células intestinais por Giardia Intestinalis, para a preparação de um veículo que pode ser ingerido para o tratamento e/ou profilaxia de distúrbios associados com a colonização do intestino por Giardia Intestinalis. A presente invenção também pertence a cepas específicas de Bifidobactérias tendo as características acima e ao veículo que pode ser ingerido, tal como uma composição alimentícea ou farmacêutica, contendo tal sobrenadante ou os microorganismos.
BRPI0015102-5A 1999-10-26 2000-10-13 Uso de sobrenadante de cultura de bactéria de ácido lático ou bifidobacterium e composição alimentícia ou farmacêutica compreendendo o referido sobrenadante BR0015102B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP99121356.2 1999-10-26
EP99121356 1999-10-26
PCT/EP2000/010105 WO2001030365A1 (en) 1999-10-26 2000-10-13 Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis

Publications (2)

Publication Number Publication Date
BR0015102A true BR0015102A (pt) 2002-07-16
BR0015102B1 BR0015102B1 (pt) 2014-03-18

Family

ID=8239282

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0015102-5A BR0015102B1 (pt) 1999-10-26 2000-10-13 Uso de sobrenadante de cultura de bactéria de ácido lático ou bifidobacterium e composição alimentícia ou farmacêutica compreendendo o referido sobrenadante

Country Status (19)

Country Link
US (2) US6905679B1 (pt)
EP (1) EP1227827B1 (pt)
CN (1) CN1281220C (pt)
AP (1) AP1563A (pt)
AR (1) AR026248A1 (pt)
AT (1) ATE290393T1 (pt)
AU (1) AU1025001A (pt)
BR (1) BR0015102B1 (pt)
CA (1) CA2388952C (pt)
CO (1) CO5280049A1 (pt)
DE (1) DE60018591T2 (pt)
DK (1) DK1227827T3 (pt)
ES (1) ES2239622T3 (pt)
MX (1) MXPA02004115A (pt)
OA (1) OA12074A (pt)
PE (1) PE20010676A1 (pt)
PT (1) PT1227827E (pt)
WO (1) WO2001030365A1 (pt)
ZA (1) ZA200203008B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1227827B1 (en) 1999-10-26 2005-03-09 Societe Des Produits Nestle S.A. Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis
GB0124580D0 (en) 2001-10-12 2001-12-05 Univ Reading New composition
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
CA2607949C (en) 2005-05-31 2012-09-25 Thomas William-Maxwell Boileau Feline probiotic bifidobacteria
AR052472A1 (es) 2005-05-31 2007-03-21 Iams Company Lactobacilos probioticos para felinos
AU2008211600B8 (en) 2007-02-01 2014-02-13 Mars, Incorporated Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US9232813B2 (en) * 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
CA2761444C (en) * 2009-05-11 2018-04-24 Nestec S.A. Lactobacillus johnsonii la1 ncc533 (cncm i-1225) and immune disorders
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
EP3011966A1 (en) 2014-08-08 2016-04-27 Institut National De La Recherche Agronomique Compositions for the inhibition of Giardia Lamblia

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69219768T2 (de) * 1992-07-06 1997-08-28 Societe Des Produits Nestle S.A., Vevey Milchbakterien
SE9501056D0 (sv) * 1995-03-23 1995-03-23 Probi Ab Epithelial adherent lactobacilli
US5902578A (en) * 1996-03-25 1999-05-11 Abbott Laboratories Method and formula for the prevention of diarrhea
ES2226228T5 (es) * 1999-04-30 2009-01-16 Societe Des Produits Nestle S.A. Crecimiento mejorado de las bacterias del acido lactico en la leche.
EP1227827B1 (en) 1999-10-26 2005-03-09 Societe Des Produits Nestle S.A. Lactic acid bacteria for the treatment and/or prophylaxis of giardiasis

Also Published As

Publication number Publication date
ZA200203008B (en) 2003-09-23
OA12074A (en) 2006-05-04
CA2388952C (en) 2008-06-10
AR026248A1 (es) 2003-02-05
DE60018591T2 (de) 2006-04-13
CN1281220C (zh) 2006-10-25
PE20010676A1 (es) 2001-07-11
CN1382056A (zh) 2002-11-27
MXPA02004115A (es) 2002-10-17
CO5280049A1 (es) 2003-05-30
BR0015102B1 (pt) 2014-03-18
AU1025001A (en) 2001-05-08
AP1563A (en) 2006-02-02
CA2388952A1 (en) 2001-05-03
US7229616B2 (en) 2007-06-12
DK1227827T3 (da) 2005-07-11
US20050186191A1 (en) 2005-08-25
EP1227827A1 (en) 2002-08-07
WO2001030365A1 (en) 2001-05-03
DE60018591D1 (de) 2005-04-14
US6905679B1 (en) 2005-06-14
ATE290393T1 (de) 2005-03-15
EP1227827B1 (en) 2005-03-09
PT1227827E (pt) 2005-07-29
AP2002002483A0 (en) 2002-06-30
ES2239622T3 (es) 2005-10-01

Similar Documents

Publication Publication Date Title
BR0008912A (pt) Cepas de bactérias do ácido láctico capazes de prevenir a diarréia
MY124559A (en) Anti-stress agent and functional food having anti-stress effect
MXPA02011632A (es) Inhibidores de 11-beta-hidroxiesteroide deshidrogenasa tipo 1.
EP3326634A3 (en) Composition for use in stimulating the intestinal flora in infants delivered by caesarean section
BR0015102A (pt) Bactérias de ácido latico para o tratamento e/ou profilaxia de giardìase
MXPA04004842A (es) Inhibidores de 11-(-hidroxiesteroide deshidrogenasa de tipo 1.
MXPA04004837A (es) Inhibidores de 11-??-hidroxiesteroide deshidrogenasa de tipo 1.
IL161154A0 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
BR0112685A (pt) Composição nutricional
MXPA05000880A (es) Probioticos para funciones neuromusculares del intestino.
BG103969A (en) C-4"-substituted macrolide derivatives
DE69924141D1 (de) Orale verabreichung von laktobacillus zur behandlung und prävention von urogenitalen infektionen
BR0112918A (pt) Composto, utilização do mesmo, processo de tratamento de distúrbios, processo para a preparação de composto, composição farmacêutica que compreende esse composto, processo para preparar uma composição e processo de tratamento de obesidade em um ser humano
WO2001052667A3 (en) Pet food composition for treating helicobacter species in pets
BR0008920A (pt) Cepas de lactobacillus capazes de prevenirdiarréia causada por bactéria patogênica erotaviroses
TW200503735A (en) Composition and method for viral inhibition
WO1998013068A1 (fr) Medicament prophylactique 'trisan'
ATE221783T1 (de) Pharmazeutische zusammensetzungen welche lactobacillus plantarum und arginin beinhalten
RS44204A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
Saksena et al. Bordetella trematum bacteremia in an infant: a cause to look for
SE9704584L (sv) Framställning av konjugerad linolsyra
EP0194794A3 (en) Saccharide digestion inhibiting composition
DE69418218D1 (de) Chinolonylcarboxamidocephalosporin-derivate und diese enthaltende arzneimittel
BR0012973B1 (pt) Uso de bactéria do ácido láctico pertencente ao gênero Bifidobacterium, e composição alimentícia ou farmacêutica.
RS44304A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 18/03/2014, OBSERVADAS AS CONDICOES LEGAIS.

B15K Others concerning applications: alteration of classification

Ipc: C12R 1/01 (2006.01), A23C 9/123 (2006.01), A23L 29

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time
B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2483 DE 07-08-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.